Skip to main content
. 2021 Aug 19;12:710240. doi: 10.3389/fendo.2021.710240

Figure 2.

Figure 2

Kaplan-Meier analyses for different endpoints among the three groups: (A) major adverse cardiovascular or cerebrovascular events (MACCE), (B) major advances cardiovascular events (MACE), (C) all-cause death, (D) cardiac death, (E) myocardial infarction, (F) stroke, (G) target vessel revascularization (TVR).